Dr. Herbst on a Smoking Cessation Trial for Lung Cancer
Roy S. Herbst, MD, PhD, ensign professor of Medicine, professor of Pharmacology, chief of Medical Oncology, associate director for Translational Research, Yale Cancer Center and Smilow Cancer Hospital, discusses a smoking cessation trial for patients with lung cancer.
Roy S. Herbst, MD, PhD, ensign professor of Medicine, professor of Pharmacology, chief of Medical Oncology, associate director for Translational Research, Yale Cancer Center and Smilow Cancer Hospital, discusses a smoking cessation trial for patients with lung cancer.
Smoking is the cause of lung cancer in over 80% of patients, explains Herbst. When people come in to be screened it is an important time to discusses the importance of smoking cessation.
It is being investigated if positive reinforcement has more of an impact on a patient looking to quit smoking, states Herbst.
